Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentJoseph Keane, M. Miles Braun, John Kasznica et al.|New England Journal of Medicine|2001Cited by 3.7k
Postinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop ReportSara C. Auld, Scott E. Evans, Ajay Sheshadri et al.|Annals of the American Thoracic Society|2024Cited by 22